Portfolio company
Cellbricks
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Cellbricks develops 3D-bioprinted human tissue implants and vascularised therapeutics for patients with complex wounds, soft tissue defects and organ damage.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Brinter
This company develops 3D-bioprinted regenerative medical implants for healthcare providers to treat patients requiring breast reconstruction and orthopedic repairs.
Cellink
This company develops 3D bioprinters and bioinks for researchers in academic, pharmaceutical and industrial laboratories to create human tissue models and organs.
Klona Biotech
The company develops 3D-bioprinted structural human tissue implants, such as ligaments and tendons, for healthcare providers and patients requiring reconstructive surgery.
Carcinotech
Carcinotech manufactures 3D-bioprinted, patient-derived tumour models for drug developers and oncologists to perform rapid and ethical cancer drug testing and personalised medicine.
Dimension Bio
This company develops 3D-printed regenerative implants and tissue-like therapies to restore organ and tissue function for patients with disease, trauma, or ageing.
CERHUM
This company manufactures 3D-printed bioceramic bone grafts and patient-specific implants for surgeons performing maxillofacial, dental, and orthopaedic reconstructions.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Cellino
The company develops an autonomous biomanufacturing platform to produce personalised stem cell therapies for patients with chronic degenerative diseases.
